Literature DB >> 27146120

Abnormalities of the Mitral Apparatus in Hypertrophic Cardiomyopathy: Echocardiographic, Pathophysiologic, and Surgical Insights.

Jeffrey J Silbiger1.   

Abstract

Hypertrophic cardiomyopathy is a genetic disorder characterized by increased cardiac muscle mass. This disorder has broad phenotypic expression, including, among others, asymmetric septal hypertrophy, midcavity hypertrophy, and apical hypertrophy. In recent years, it has been recognized that hypertrophic cardiomyopathy is not characterized solely by ventricular hypertrophy but that a number of abnormalities of the mitral apparatus (papillary muscles, leaflets, chords, and annulus) may also occur. These figure prominently in the echocardiographic evaluation and surgical planning of patients with hypertrophic cardiomyopathy and serve as the focus of this review.
Copyright © 2016 American Society of Echocardiography. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Anderson-Fabry disease; Athlete's heart; Cardiac amyloidosis; Echocardiography; Hypertrophic cardiomyopathy; Left ventricular outflow tract obstruction; Midventricular obstruction; Papillary muscle abnormalities; Systolic anterior motion

Mesh:

Year:  2016        PMID: 27146120     DOI: 10.1016/j.echo.2016.03.003

Source DB:  PubMed          Journal:  J Am Soc Echocardiogr        ISSN: 0894-7317            Impact factor:   5.251


  8 in total

1.  Septal Thickness Does Not Impact Outcome After Hypertrophic Obstructive Cardiomyopathy Surgery (Septal Myectomy and Subvalvular Mitral Apparatus Remodeling): A 15-Years of Experience.

Authors:  Giuseppe M Raffa; Eluisa La Franca; Carlo Lachina; Andrea Palmeri; Mariusz Kowalewski; Steven Lebowitz; Alessandro Ricasoli; Matteo Greco; Sergio Sciacca; Marco Turrisi; Marco Morsolini; Vincenzo Stringi; Gabriella Mattiucci; Michele Pilato
Journal:  Front Cardiovasc Med       Date:  2022-06-15

Review 2.  Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review.

Authors:  Steven Lebowitz; Mariusz Kowalewski; Giuseppe Maria Raffa; Danny Chu; Matteo Greco; Caterina Gandolfo; Carmelo Mignosa; Roberto Lorusso; Piotr Suwalski; Michele Pilato
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

Review 3.  Systolic anterior motion of the mitral valve in hypertrophic cardiomyopathy: a narrative review.

Authors:  Sarah A Guigui; Christian Torres; Esteban Escolar; Christos G Mihos
Journal:  J Thorac Dis       Date:  2022-06       Impact factor: 3.005

Review 4.  Mitral Valve Disease in Hypertrophic Cardiomyopathy:Evaluation and Management.

Authors:  C Charles Jain; Darrell B Newman; Jeffrey B Geske
Journal:  Curr Cardiol Rep       Date:  2019-10-31       Impact factor: 2.931

5.  Anomalous Papillary Muscle Insertion Causing Dynamic Left Ventricular Outflow Tract Obstruction without Hypertrophic Obstructive Cardiomyopathy.

Authors:  Ravi Korabathina; Katherine Chiu; Hugh M van Gelder; Arthur Labovitz
Journal:  Case Rep Cardiol       Date:  2017-05-15

6.  Characteristics and Surgical Results of Patients with Hypertrophic Obstructive Cardiomyopathy without Intrinsic Mitral Valve Diseases Undergoing Mitral Subvalvular Procedures during Myectomy.

Authors:  Qiang Ji; YuLin Wang; Ye Yang; LiMin Xia; WenJun Ding; Kai Song; ChunSheng Wang
Journal:  Cardiol Res Pract       Date:  2020-12-09       Impact factor: 1.866

7.  Mid-ventricular obstruction in a patient with hypertrophic cardiomyopathy.

Authors:  Kevin Rafael De Paula Morales; Cristhian Vicente Espinoza Romero; Williams Roberto Lata Guacho; David Alejandro Salazar Jaya; Eduardo Kaiser Ururahy Nunes Fonseca
Journal:  Einstein (Sao Paulo)       Date:  2022-04-22

8.  Significant left ventricular outflow tract obstruction secondary to systolic anterior motion in a patient without hypertrophic cardiomyopathy: An echocardiographic study.

Authors:  Hanan Alrammah; Sami Ghazal
Journal:  J Saudi Heart Assoc       Date:  2018-07-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.